Aldosterone blockade in chronic kidney disease: can it improve outcome?
RD Toto - Current opinion in nephrology and hypertension, 2010 - journals.lww.com
RD Toto
Current opinion in nephrology and hypertension, 2010•journals.lww.comAt this time it is unknown whether mineralocorticoid receptor blockade can improve
outcomes in patients with CKD. To move this field forward and determine whether these
agents can improve the lives of patients with kidney disease, novel strategies to prevent or
ameliorate hyperkalemia are needed.
outcomes in patients with CKD. To move this field forward and determine whether these
agents can improve the lives of patients with kidney disease, novel strategies to prevent or
ameliorate hyperkalemia are needed.
Summary
At this time it is unknown whether mineralocorticoid receptor blockade can improve outcomes in patients with CKD. To move this field forward and determine whether these agents can improve the lives of patients with kidney disease, novel strategies to prevent or ameliorate hyperkalemia are needed.
Lippincott Williams & Wilkins